» Articles » PMID: 36307418

Prevalence and Mechanisms of Evolutionary Contingency in Human Influenza H3N2 Neuraminidase

Abstract

Neuraminidase (NA) of human influenza H3N2 virus has evolved rapidly and been accumulating mutations for more than half-century. However, biophysical constraints that govern the evolutionary trajectories of NA remain largely elusive. Here, we show that among 70 natural mutations that are present in the NA of a recent human H3N2 strain, >10% are deleterious for an ancestral strain. By mapping the permissive mutations using combinatorial mutagenesis and next-generation sequencing, an extensive epistatic network is revealed. Biophysical and structural analyses further demonstrate that certain epistatic interactions can be explained by non-additive stability effect, which in turn modulates membrane trafficking and enzymatic activity of NA. Additionally, our results suggest that other biophysical mechanisms also contribute to epistasis in NA evolution. Overall, these findings not only provide mechanistic insights into the evolution of human influenza NA and elucidate its sequence-structure-function relationship, but also have important implications for the development of next-generation influenza vaccines.

Citing Articles

Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.

Lei R, Kim W, Lv H, Mou Z, Scherm M, Schmitz A Immunity. 2023; 56(11):2621-2634.e6.

PMID: 37967533 PMC: 10655865. DOI: 10.1016/j.immuni.2023.10.005.


Phylogenetic identification of influenza virus candidates for seasonal vaccines.

Hayati M, Sobkowiak B, Stockdale J, Colijn C Sci Adv. 2023; 9(44):eabp9185.

PMID: 37922357 PMC: 10624341. DOI: 10.1126/sciadv.abp9185.


Co-evolution of immunity and seasonal influenza viruses.

Han A, de Jong S, Russell C Nat Rev Microbiol. 2023; 21(12):805-817.

PMID: 37532870 DOI: 10.1038/s41579-023-00945-8.


Mutational fitness landscape of human influenza H3N2 neuraminidase.

Lei R, Hernandez Garcia A, Tan T, Teo Q, Wang Y, Zhang X Cell Rep. 2023; 42(1):111951.

PMID: 36640354 PMC: 9931530. DOI: 10.1016/j.celrep.2022.111951.


Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase.

Lei R, Tan T, Hernandez Garcia A, Wang Y, Diefenbacher M, Teo C Nat Commun. 2022; 13(1):6443.

PMID: 36307418 PMC: 9616408. DOI: 10.1038/s41467-022-34060-8.

References
1.
Gong L, Suchard M, Bloom J . Stability-mediated epistasis constrains the evolution of an influenza protein. Elife. 2013; 2:e00631. PMC: 3654441. DOI: 10.7554/eLife.00631. View

2.
Chen V, Arendall 3rd W, Headd J, Keedy D, Immormino R, Kapral G . MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 1):12-21. PMC: 2803126. DOI: 10.1107/S0907444909042073. View

3.
Miton C, Tokuriki N . How mutational epistasis impairs predictability in protein evolution and design. Protein Sci. 2016; 25(7):1260-72. PMC: 4918425. DOI: 10.1002/pro.2876. View

4.
Wang Y, Lei R, Nourmohammad A, Wu N . Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing. Elife. 2021; 10. PMC: 8683081. DOI: 10.7554/eLife.72516. View

5.
Zhang J, Kobert K, Flouri T, Stamatakis A . PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics. 2013; 30(5):614-20. PMC: 3933873. DOI: 10.1093/bioinformatics/btt593. View